Therapeutic Antibodies for the Treatment of Pancreatic Cancer
Pancreatic cancer is a devastating disease with the worst mortality rate and an overall 5-year survival rate lower than 5%. In the U.S., this disease is the fourth leading cause of death and represents 6% of all cancer-related deaths. Gemcitabine, the current standard first-line treatment, offers ma...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wiley
2010-01-01
|
| Col·lecció: | The Scientific World Journal |
| Accés en línia: | http://dx.doi.org/10.1100/tsw.2010.103 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|